Hsbc Holdings PLC bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 428,065 shares of the medical device company’s stock, valued at approximately $30,678,000. Hsbc Holdings PLC owned approximately 0.22% of Cooper Companies at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Ancora Advisors LLC purchased a new position in Cooper Companies in the 2nd quarter valued at approximately $2,394,000. Expect Equity LLC purchased a new stake in shares of Cooper Companies during the second quarter worth $3,015,000. Legal & General Group Plc purchased a new stake in shares of Cooper Companies during the second quarter worth $60,521,000. The Manufacturers Life Insurance Company acquired a new stake in shares of Cooper Companies in the second quarter valued at $69,129,000. Finally, Sone Capital Management LLC purchased a new position in Cooper Companies in the second quarter valued at $27,754,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of brokerages have recently commented on COO. Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a research report on Sunday, June 21st. JPMorgan Chase & Co. decreased their price target on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research note on Friday, June 5th. UBS Group started coverage on shares of Cooper Companies in a report on Tuesday, July 28th. They set a “neutral” rating and a $75.00 price target for the company. Mizuho set a $85.00 price objective on shares of Cooper Companies and gave the company an “outperform” rating in a research report on Thursday, June 4th. Finally, Piper Sandler set a $86.00 price objective on shares of Cooper Companies and gave the company an “overweight” rating in a report on Monday, June 1st. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, Cooper Companies has an average rating of “Hold” and an average price target of $81.64.
Cooper Companies Price Performance
Shares of NASDAQ:COO opened at $70.96 on Friday. The company has a 50-day simple moving average of $72.46 and a 200-day simple moving average of $70.88. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The stock has a market capitalization of $13.84 billion, a price-to-earnings ratio of 60.14, a PEG ratio of 1.90 and a beta of 0.83.
Cooper Companies (NASDAQ:COO – Get Free Report) last released its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The firm had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business’s revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the company posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, analysts predict that The Cooper Companies, Inc. will post 4.63 EPS for the current year.
Cooper Companies Company Profile
Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.
The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.
Featured Stories
- Five stocks we like better than Cooper Companies
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
